Healthcare -
Biotechnology - NASDAQ - US
$ 1.71
-2.84 %
$ 1.09 B
Market Cap
-6.33
P/E
GERN - RESEARCH & DEVELOPMENT
Research & Development GERN - Geron Corporation
125 M
LAST VALUE
20.77%
2 YEAR CAGR
56.24%
5 YEAR CAGR
18.37%
10 YEAR CAGR